Location History:
- Denver, CO (US) (2001)
- Evergreen, CO (US) (1996 - 2004)
Company Filing History:
2 out of 126 
2 out of 6,850 
1 out of 20 Years Active: 1996-2004
Title: **Claude P. Selitrennikoff: A Pioneer in Antimicrobial Research**
Introduction
Claude P. Selitrennikoff, based in Evergreen, Colorado, is a notable inventor with a record of ten patents. His contributions primarily focus on microbial enzyme activities and the development of novel antimicrobial agents. His innovative work aims to combat fungal infections and improve methods for identifying effective treatments.
Latest Patents
Selitrennikoff's most recent patents showcase his expertise in fungal research. One significant invention involves methods for the identification of fungal glucose utilization inhibitors and antifungal agents. The invention provides techniques to assess microbial phosphoglucose isomerase, ketol-isomerase, and glucosamine-6-phosphate acetyltransferase activities, allowing for the measurement of Coenzyme A (CoA) production. This method enables the isolation of new classes of antifungal drugs aimed at disrupting fungal glucose utilization.
Additionally, he has developed methods for the identification of antimicrobial compounds, which relate to the assay of 2-amino-2-deoxy-D-glucose-6-phosphate ketol-isomerase activity. These methods serve drug screening purposes, identifying compounds that exhibit antimicrobial activity by inhibiting microbial ketol-isomerase activity. The techniques he has pioneered can selectively target microbial enzymes, providing a mechanism for treating infections more effectively.
Career Highlights
Throughout his career, Selitrennikoff has worked with various organizations, including the Ciba-Geigy Corporation. His work has significantly advanced our understanding of microbial enzyme mechanisms and has contributed to the development of new therapeutic approaches against infections.
Collaborations
Collaboration has been key in Selitrennikoff’s career, and he has worked alongside esteemed colleagues such as Walden K. Roberts and Bridget E. Laue. Working with such talented professionals has enhanced his research capabilities and expanded the impact of his discoveries in the field of antimicrobial agents.
Conclusion
Claude P. Selitrennikoff stands out as an influential inventor in the field of antimicrobial research. His ten patents reflect a dedication to understanding and combating microbial threats. Through his innovative methods and collaborations, he continues to make significant strides in the development of effective antifungal and antimicrobial therapies.